Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome.
Ter Avest M, Steenbreker H, Bouwmeester RN, Duineveld C, Wijnsma KL, van den Heuvel LPWJ, Langemeijer SMC, Wetzels JFM, van de Kar NCAJ, Ter Heine R; CUREiHUS Study Group. Ter Avest M, et al. Among authors: wetzels jfm. Clin J Am Soc Nephrol. 2023 Jun 1;18(6):759-766. doi: 10.2215/CJN.0000000000000145. Epub 2023 Apr 10. Clin J Am Soc Nephrol. 2023. PMID: 36913245
COVID-19 vaccination and Atypical hemolytic uremic syndrome.
Bouwmeester RN, Bormans EMG, Duineveld C, van Zuilen AD, van de Logt AE, Wetzels JFM, van de Kar NCAJ. Bouwmeester RN, et al. Among authors: wetzels jfm. Front Immunol. 2022 Dec 1;13:1056153. doi: 10.3389/fimmu.2022.1056153. eCollection 2022. Front Immunol. 2022. PMID: 36531998 Free PMC article.
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study.
Bouwmeester RN, Duineveld C, Wijnsma KL, Bemelman FJ, van der Heijden JW, van Wijk JAE, Bouts AHM, van de Wetering J, Dorresteijn E, Berger SP, Gracchi V, van Zuilen AD, Keijzer-Veen MG, de Vries APJ, van Rooij RWG, Engels FAPT, Altena W, de Wildt R, van Kempen E, Adang EM, Ter Avest M, Ter Heine R, Volokhina EB, van den Heuvel LPWJ, Wetzels JFM, van de Kar NCAJ. Bouwmeester RN, et al. Among authors: wetzels jfm. Kidney Int Rep. 2022 Oct 18;8(1):91-102. doi: 10.1016/j.ekir.2022.10.013. eCollection 2023 Jan. Kidney Int Rep. 2022. PMID: 36644349 Free PMC article.
Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation.
Duineveld C, Bouwmeester RN, Wijnsma KL, Bemelman FJ, van der Heijden JW, Berger SP, van den Heuvel LPWJ, van de Kar NCAJ, Wetzels JFM; Dutch aHUS Working Group. Duineveld C, et al. Among authors: wetzels jfm. Kidney Int Rep. 2023 Jan 19;8(4):715-726. doi: 10.1016/j.ekir.2023.01.016. eCollection 2023 Apr. Kidney Int Rep. 2023. PMID: 37069997 Free PMC article.
Modeling complement activation on human glomerular microvascular endothelial cells.
Stevens KH, Baas LM, van der Velden TJAM, Bouwmeester RN, van Dillen N, Dorresteijn EM, van Zuilen AD, Wetzels JFM, Michels MAHM, van de Kar NCAJ, van den Heuvel LP. Stevens KH, et al. Among authors: wetzels jfm. Front Immunol. 2023 Oct 25;14:1206409. doi: 10.3389/fimmu.2023.1206409. eCollection 2023. Front Immunol. 2023. PMID: 37954621 Free PMC article.
A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: "Eculizumab first" in the management of posttransplant thrombotic microangiopathy.
Duineveld C, van de Kar NCAJ, Wetzels JFM. Duineveld C, et al. Among authors: wetzels jfm. Kidney Int Rep. 2024 Mar 1;9(5):1538. doi: 10.1016/j.ekir.2024.02.1434. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707808 Free PMC article. No abstract available.
334 results